Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.8429
-0.0069 (-0.81%)
At close: Sep 3, 2025, 4:00 PM
0.8260
-0.0169 (-2.00%)
After-hours: Sep 3, 2025, 7:52 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $75.61 million as of September 3, 2025. Its market cap has decreased by -61.37% in one year.
Market Cap
75.61M
Enterprise Value
-7.74M
1-Year Change
-61.37%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $75.61M, an increase of 48.18%. That is a compound annual growth rate of 10.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2025 | 75.61M | -19.72% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.01B |
| Johnson & Johnson | 428.83B |
| AbbVie | 374.37B |
| UnitedHealth Group | 279.67B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 228.80B |